mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.7 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.7 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.7 |